Expired Canadian patentCanada
Gene therapy for diabetic ischemic disease
CA 2356701 C · Owner: Ogihara, Toshio · Inventors: Morishita, Ryuichi; Ogihara, Toshio
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
It is possible to stimulate the angiogenesis of an ischemic site declined by diabetes and to recuperate ischemic disease by administering HGF (hepatocyte growth factor) gene to the diabetic ischemic site.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 26, 2000 and granted February 15, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 26, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 26, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 26, 2000
GrantedFebruary 15, 2011
Term endedOctober 26, 2020
Patent numberCA 2356701 C
Classification (IPC)A61K48/00 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.